Home › Funds › EMINENCE CAPITAL, LP › THC

EMINENCE CAPITAL, LP position in THC

TENET HEALTHCARE CORP · Health Care

EMINENCE CAPITAL, LP reported holding 790,302 shares of THC (TENET HEALTHCARE CORP) in its Q1 2026 13F filing — a position valued at US$149.1M, representing 3.42% of its reported portfolio and ranking #13 among its reported holdings. EMINENCE CAPITAL, LP has disclosed THC holdings in 3 of the last 3 reported quarters, going back to Q3 2025.

Latest position (Q1 2026)790.30K sh
Reported value held$149.14M
Portfolio Weight3.42%
First reportedQ3 2025
Last changeAdd
Updated2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

How EMINENCE CAPITAL, LP's THC position evolved

EMINENCE CAPITAL, LP first disclosed a stake in THC in Q3 2025 at 1,109,450 shares (US$225.3M). Across 3 filings, EMINENCE CAPITAL, LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q1 2026) shows 790,302 shares valued at US$149.1M — an increase of 176,341 shares quarter over quarter.. Notable position changes include a 45% trim in Q4 2025 (shares fell 5% over the following quarter), a 29% increase in Q1 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 1.11M $225.26M New
Q4 2025 613.96K $122.01M Reduce
Q1 2026 790.30K $149.14M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About THC and 13F data

THC (TENET HEALTHCARE CORP) is a Health Care company. 39 other funds we track also report a position in THC — the largest reported positions include Boston Partners (US$829.1M), GLENVIEW CAPITAL MANAGEMENT, LLC (US$418.2M), MANNING & NAPIER ADVISORS LLC (US$168.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding THC

All THC fund holders →

FAQ

How long has EMINENCE CAPITAL, LP held THC?

EMINENCE CAPITAL, LP has disclosed THC holdings in 3 of the last 3 reported quarters, going back to Q3 2025.

What is EMINENCE CAPITAL, LP's current position in THC?

As of Q1 2026, EMINENCE CAPITAL, LP holds 790.30K shares of THC (TENET HEALTHCARE CORP), valued at $149.14M, representing 3.42% of its reported portfolio and ranking #13.

Has EMINENCE CAPITAL, LP been buying or selling THC?

In the latest 13F filing (Q1 2026), EMINENCE CAPITAL, LP increased its position in THC.

Which other funds hold THC?

Other major institutional holders of THC include Boston Partners, GLENVIEW CAPITAL MANAGEMENT, LLC, MANNING & NAPIER ADVISORS LLC, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.